{"name":"LifeMine Therapeutics","slug":"lifemine-therapeutics","ticker":"","exchange":"","domain":"lifemine.com","description":"LifeMine Therapeutics is a biotechnology company focused on discovering and developing novel therapies by leveraging its unique platform that identifies and validates drug targets in the human microbiome. The company is advancing a pipeline of candidates, including two lead programs in early clinical stages, aimed at addressing significant unmet medical needs.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxPcFdLbk9qTkFCVVIxd1Myb2psX0U3clVuVnJVQ2JjNnlXa2hkZ3FCajhaaFpvcHhkNFVWSlppRjlhZDNyblY2ZG1jenlJdUduc0E0eXhiSjR2eUVmUXQ5ZlhSejRyRFVvbWNrS0phYmJBT1BsSm82RHFRMFh2OG9IS1hHNTNhd1gwamYyM1IwSnFwU3Jq?oc=5","date":"2025-04-17","type":"earnings","source":"BioSpace","summary":"Q1 Biopharma Layoffs Hit California, Massachusetts Hard - BioSpace","headline":"Q1 Biopharma Layoffs Hit California, Massachusetts Hard","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxOREpiNUNDRkN4VkJtWHdkSTByNTc2ZUkzRDg1ZFlETU1CTkJPbGpUVF95X2RhVTQtby1DVUhEY2E1T0pxcEJFczJHTjBqNEJHSWxRMFZpSFVxcHRrMWVtRkJfOUt2LVhuZVRJSFg0WllpcUZiaENVUDFDVnpidlhJSHRpZlozSm1hRzI3R1BQb2pQN0R5ZVVnaDRibw?oc=5","date":"2023-10-13","type":"pipeline","source":"The Business Journals","summary":"For biotech entrepreneur Greg Verdine, opportunity just kept knocking - The Business Journals","headline":"For biotech entrepreneur Greg Verdine, opportunity just kept knocking","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiaEFVX3lxTE5pcFM1a3BpZG43UUllRjU3WmpfZkxZbHJkdDVGcUUzME1RcEFNR2I2NnNwZEJZNlFhZHhVNjJmTGs0amljbmstYVNIUUFLUWlaN3Ytek80djJLZGNBSXgyNjVPUlQ4OXhZ?oc=5","date":"2023-07-20","type":"deal","source":"a16z.com","summary":"Greg Verdine, Bio + Health Venture Partner - a16z.com","headline":"Greg Verdine, Bio + Health Venture Partner - a16z.com","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE4wM1lwNThaWDlPVmZoaFFLc1FLOTExQ1pXcHQtS0JRb1hLdWJRcVBScDVHTUsxNWFZaENvYWJ4VEtFaEJBNTJmZFhLVVZIRTZGN3hJRnRRRmJrMHd2ZXJJ?oc=5","date":"2022-12-07","type":"pipeline","source":"Nature","summary":"People - Nature","headline":"People","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxOeGdiLWNUSlJ4MjRMR1Zsa2tGVm5Ud05faFlNbW9Rc2dvMTFhTVg0Rm9mb2hNc3ctalJEb2ozSHFjLTlDZTgwbGNkR3VsSHhZVENKWi01eWlsb2VBcER3aTZqN3JVXzBhX0NKTVViV1RmT05WU2FOeFJoT3BHQ3pDb1VjaGgwcll2aEV0SjNqQkREX3otWGpDbXYxand0Q3JqQ2tBdUVMOURsWGJxOUw3Mw?oc=5","date":"2022-09-16","type":"pipeline","source":"Business Insider","summary":"Why a top Roche scientist is leaving after 25 years to join a rising biotech startup using fungi to make new drugs - Business Insider","headline":"Why a top Roche scientist is leaving after 25 years to join a rising biotech startup using fungi to make new drugs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTE1FUEJSSm9kbTlPT3d3XzlRM0NGYmlIYTlYbFNaSV9LV1VCQlF3R3J6Yy1FeVBpZUZaUVpvbWFXVWRIX29XNkxJTVhXNVdERUtJRjBjVkpEZHZKQ3Z3aEM5TC1Ba291X3l4YTBmUGNEcXBWUnZpNkZ5dmhQemcwdw?oc=5","date":"2022-09-06","type":"pipeline","source":"Pharma Voice","summary":"Entrepreneurs: WeiQing Zhou - Pharma Voice","headline":"Entrepreneurs: WeiQing Zhou","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE9COGtKcG96Rk5TcG5VU0kzQ2hlcUhqODhaUElDcW9ROTgtREx0RWpxZTdPVE41b3hNNFJfRzVaUl9lQVFBdkdKdTBka200bEhMNWhzd0ROV0lSaEpnRFNB?oc=5","date":"2022-05-16","type":"pipeline","source":"Nature","summary":"Fungal genomes scoured for drugs - Nature","headline":"Fungal genomes scoured for drugs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxPNVlZa0hiOEpiZGlGT0twVlZONUZKTnhERGktOTVoOVk4RndKWmo2LVhJNjNFMUtka29mNkJJdTBHeHUxNXh3OTZfam1KZ0ktZXRwUzQ0NlFDVldRY0Z4UnJxT0xaUTZRMmFiXzBqdkU5MTh0eHVBd2wxVDZyaEdnMms3VnI?oc=5","date":"2022-03-24","type":"deal","source":"pharmaphorum","summary":"GSK partners LifeMine on fungi-derived medicines - pharmaphorum","headline":"GSK partners LifeMine on fungi-derived medicines","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxOYl9zRWRQbHJxNmtLMlQ3OWZIejV2MTlRWFFDWU9wbkNiYlBlaXBRdUhvTk14clJjNV9qdDFlY01FWW5ZdnJuQ3BDcXRlN2JFbTZjbEJVNl9rN3QtdkRjUVFGOUlLU3J0dFhUU2ljSXFNQUo5NXd4S0tnaHQ1cndfd3BKUGRCUVF6c01VLUlSZGVZVEk?oc=5","date":"2022-03-23","type":"deal","source":"BioPharma Dive","summary":"GSK partners with LifeMine as startups advance plans to make drugs from fungi - BioPharma Dive","headline":"GSK partners with LifeMine as startups advance plans to make drugs from fungi","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxPQy01TTY1cUIyZ3NqVm5feWxqdG1TdWtKZi12cHFfVjhJUkM5ci11X2NVTHhVS0ZWSmRlelZoX1ItNEhpcEZNRTJqSDZvaTBvNjJxNkJoQmN2MHBqcVh4Zkt1OVZCWW9jUUpuVjlvYVQ3dTRsdTAxTXh4aFU4VWt0SVRqV3JjUkNraXlHQjhrUHRyZUZZVm1PS0NGNFZNcWlGMDBvNHUxQVVhOWRpdkpDdGFvTWZrR0NBb3c?oc=5","date":"2022-03-23","type":"deal","source":"Fierce Biotech","summary":"LifeMine locks down $70M 'dream scenario' fungi partnership with GSK—and a fundraising, too - Fierce Biotech","headline":"LifeMine locks down $70M 'dream scenario' fungi partnership with GSK—and a fundraising, too","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTFA1Q19pdmhmV3VrWElBa3hNSVFFNTlQSHNKa29iMlpfN09pYU5jcnBDclVXNWNGSDN3Q1NGTjZEOWVGQUh2T0hvTVFtRlhaRWZ6TkdpQWpoaHVHTVpUZFFwT3E1QkY3WkV1TWZVZlJIbWkzLXgtSU9J?oc=5","date":"2021-11-15","type":"pipeline","source":"Fierce Pharma","summary":"2021's Fiercest Women in Life Sciences - Fierce Pharma","headline":"2021's Fiercest Women in Life Sciences","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPcmQxdGc0X3p4c2xNRHBxOVB1UUFvRGR1MS1fYThtTVpqM2EzaDdSWUNtNTRPSk94ZmNaZUF0bWFXRmJyNlJCd0lXWmxLLTEzZFFmZ013Wkc5LXR4UnNRTFJIRGI2b21sd1BFeDBHMF9zVVc0eVFqbGNJSWItb0tqSFJpMHhrc2RNTUNVVlVTUmJtdUJleTB3bGlOcVJ2eWc4a0Y5YnZR?oc=5","date":"2018-05-16","type":"pipeline","source":"PR Newswire","summary":"FogPharma Secures $66 Million Series B Financing - PR Newswire","headline":"FogPharma Secures $66 Million Series B Financing","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}